{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T00:36:42Z","timestamp":1791247002272,"version":"4.1.0"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T00:00:00Z","timestamp":1733184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100008258","name":"Hyundai Motor Group | Hyundai Motor America | Hyundai Hope On Wheels","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008258","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Associazione Italiana Linfoistiocitosi Emofagocitica"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1038\/s41409-024-02487-w","type":"journal-article","created":{"date-parts":[[2024,12,3]],"date-time":"2024-12-03T19:47:09Z","timestamp":1733255229000},"page":"406-411","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT"],"prefix":"10.1038","volume":"60","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6426-4046","authenticated-orcid":false,"given":"Pietro","family":"Merli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1791-7718","authenticated-orcid":false,"given":"Sonata","family":"Jodele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5528-4405","authenticated-orcid":false,"given":"Kasiani C.","family":"Myers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4431-643X","authenticated-orcid":false,"given":"Samppa","family":"Ryh\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Cefalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Quagliarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella M.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Teusink-Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0196-806X","authenticated-orcid":false,"given":"Paibel","family":"Aguayo-Hiraldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie L.","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8561-4076","authenticated-orcid":false,"given":"Paul","family":"Szabolcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mira","family":"Kohorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-3654","authenticated-orcid":false,"given":"Franco","family":"Locatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3652-0003","authenticated-orcid":false,"given":"Anthony","family":"Sabulski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,3]]},"reference":[{"key":"2487_CR1","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1038\/leu.2015.75","volume":"29","author":"RF Olsson","year":"2015","unstructured":"Olsson RF, Logan BR, Chaudhury S, Zhu X, Akpek G, Bolwell BJ, et al. Primary graft failure after myeloablative allogeneic hematopoietic cell transplantation for hematologic malignancies. Leukemia. 2015;29:1754\u201362.","journal-title":"Leukemia"},{"key":"2487_CR2","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1016\/j.jtct.2021.04.007","volume":"27","author":"MA Kharfan-Dabaja","year":"2021","unstructured":"Kharfan-Dabaja MA, Kumar A, Ayala E, Aljurf M, Nishihori T, Marsh R, et al. Standardizing definitions of hematopoietic recovery, graft rejection, graft failure, poor graft function, and donor chimerism in allogeneic hematopoietic cell transplantation: a report on behalf of the american society for transplantation and cellular therapy. Transpl Cell Ther. 2021;27:642\u20139.","journal-title":"Transpl Cell Ther"},{"key":"2487_CR3","doi-asserted-by":"publisher","first-page":"2314","DOI":"10.3324\/haematol.2019.216101","volume":"104","author":"P Merli","year":"2019","unstructured":"Merli P, Caruana I, De Vito R, Strocchio L, Weber G, Bufalo FD, et al. Role of interferon-gamma in immune-mediated graft failure after allogeneic hematopoietic stem cell transplantation. Haematologica. 2019;104:2314\u201323.","journal-title":"Haematologica"},{"key":"2487_CR4","doi-asserted-by":"publisher","first-page":"4594","DOI":"10.1182\/bloodadvances.2021005231","volume":"5","author":"A Sabulski","year":"2021","unstructured":"Sabulski A, Myers KC, Bleesing JJ, Duell A, Lane A, Teusink-Cross A, et al. Graft rejection markers in children undergoing hematopoietic cell transplant for bone marrow failure. Blood Adv. 2021;5:4594\u2013604.","journal-title":"Blood Adv"},{"key":"2487_CR5","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1371\/journal.pmed.0050026","volume":"5","author":"M Rottman","year":"2008","unstructured":"Rottman M, Soudais C, Vogt G, Renia L, Emile JF, Decaluwe H, et al. IFN-gamma mediates the rejection of haematopoietic stem cells in IFN-gammaR1-deficient hosts. PLoS Med. 2008;5:e26.","journal-title":"PLoS Med"},{"key":"2487_CR6","doi-asserted-by":"crossref","unstructured":"Sabulski A, Langenberg L, Luebbering N, Libermann T, Dillon S, Koo J, et al. Plasma proteome analyses identify predictors of graft rejection prior to stem cell infusion and support interferon-mediated ferroptosis as a novel mechanism of graft rejection. Transpl Cell Ther. 2024;30:S4\u20135.","DOI":"10.1016\/j.jtct.2023.12.024"},{"key":"2487_CR7","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1111\/bcp.15133","volume":"88","author":"P Jacqmin","year":"2022","unstructured":"Jacqmin P, Laveille C, Snoeck E, Jordan MB, Locatelli F, Ballabio M, et al. Emapalumab in primary haemophagocytic lymphohistiocytosis and the pathogenic role of interferon gamma: a pharmacometric model-based approach. Br J Clin Pharm. 2022;88:2128\u201339.","journal-title":"Br J Clin Pharm"},{"key":"2487_CR8","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1056\/NEJMoa1911326","volume":"382","author":"F Locatelli","year":"2020","unstructured":"Locatelli F, Jordan MB, Allen C, Cesaro S, Rizzari C, Rao A, et al. Emapalumab in children with primary hemophagocytic lymphohistiocytosis. N. Engl J Med. 2020;382:1811\u201322.","journal-title":"N. Engl J Med"},{"key":"2487_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.3390\/cells8010047","volume":"8","author":"G Ottaviano","year":"2019","unstructured":"Ottaviano G, Chiesa R, Feuchtinger T, Vickers MA, Dickinson A, Gennery AR, et al. Adoptive T cell therapy strategies for viral infections in patients receiving haematopoietic stem cell transplantation. Cells. 2019;8:47.","journal-title":"Cells"},{"key":"2487_CR10","doi-asserted-by":"publisher","first-page":"167.e1","DOI":"10.1016\/j.jtct.2021.11.017","volume":"28","author":"JC Gardner","year":"2022","unstructured":"Gardner JC, Courter JD, Dandoy CE, Davies SM, Teusink-Cross A. Safety and efficacy of prophylactic levofloxacin in pediatric and adult hematopoietic stem cell transplantation patients. Transpl Cell Ther. 2022;28:167.e1\u2013167.e5.","journal-title":"Transpl Cell Ther"},{"key":"2487_CR11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.613644","volume":"11","author":"G Weber","year":"2020","unstructured":"Weber G, Strocchio L, Del Bufalo F, Algeri M, Pagliara D, Arnone CM, et al. Identification of new soluble factors correlated with the development of graft failure after haploidentical hematopoietic stem cell transplantation. Front Immunol. 2020;11:613644.","journal-title":"Front Immunol"},{"key":"2487_CR12","doi-asserted-by":"publisher","first-page":"641","DOI":"10.3324\/haematol.2020.255620","volume":"106","author":"F Tucci","year":"2021","unstructured":"Tucci F, Gallo V, Barzaghi F, Ferrua F, Migliavacca M, Calbi V, et al. Emapalumab treatment in an ADA-SCID patient with refractory hemophagocytic lymphohistiocytosis-related graft failure and disseminated bacillus Calmette-Gu\u00e9rin infection. Haematologica. 2021;106:641\u20136.","journal-title":"Haematologica"},{"key":"2487_CR13","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/j.jaci.2023.05.016","volume":"152","author":"B Kunvarjee","year":"2023","unstructured":"Kunvarjee B, Bidgoli A, Madan RP, Vidal E, McAvoy D, Hosszu KK, et al. Emapalumab as bridge to hematopoietic cell transplant for STAT1 gain-of-function mutations. J Allergy Clin Immunol. 2023;152:815\u20137.","journal-title":"J Allergy Clin Immunol"},{"key":"2487_CR14","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/bmt.2011.162","volume":"47","author":"BM Svahn","year":"2012","unstructured":"Svahn BM, Remberger M, Alvin O, Karlsson H, Ringd\u00e9n O. Increased costs after allogeneic haematopoietic SCT are associated with major complications and re-transplantation. Bone Marrow Transpl. 2012;47:706\u201315.","journal-title":"Bone Marrow Transpl"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02487-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02487-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02487-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T07:36:45Z","timestamp":1741592205000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41409-024-02487-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["2487"],"URL":"https:\/\/doi.org\/10.1038\/s41409-024-02487-w","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,3]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 November 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2024","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"PM, FL, JLA and AS have consulted for SOBI. SJ holds US Patent 10815 296 B2, \u201cMethods of treatment of HSCT-associated thrombotic microangiopathy with eculizumab;\u201d has received research support from Alexion Pharmaceuticals; and has had consultancies with Omeros, SOBI, and Alexion.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}